ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ADVM Company Profile and Key Details

NASDAQ : ADVM

Adverum Biotechnologies, Inc.

$4.58

-0.04-0.87%

At Close 4:00 PM

$4.57

-0.01-0.22%

After-Market 03:59 PM

57.05

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

ADVM Stock Price Chart

Stock Price Today

Adverum Biotechnologies, Inc. (ADVM) stock declined over -0.87%, trading at $4.58 on NASDAQ, down from the previous close of $4.62. The stock opened at $4.60, fluctuating between $4.52 and $4.70 in the recent session.

Stock Snapshot

4.62

Prev. Close

4.6

Open

95.28M

Market Cap

20.8M

Number of Shares

4.515

Day Low

4.7

Day High

-0.77

P/E Ratio

61.76%

Free Float in %

-5.95

EPS (TTM)

8.25

Book Value

-9.07

Cash Flow per Share

77.24K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 07, 2025	4.60	4.68	4.50	4.58	77.24K
Mar 06, 2025	4.40	4.67	4.23	4.62	124.4K
Mar 05, 2025	4.24	4.49	4.23	4.40	120.46K
Mar 04, 2025	4.10	4.33	3.92	4.25	201.51K
Mar 03, 2025	4.69	5.14	4.15	4.16	267.7K
Feb 28, 2025	4.36	4.75	4.08	4.71	270.1K
Feb 27, 2025	4.10	4.76	4.01	4.40	327.6K
Feb 26, 2025	4.21	4.33	3.52	4.18	666.1K
Feb 25, 2025	3.98	4.54	3.94	4.20	397.84K
Feb 24, 2025	3.97	4.02	3.75	3.83	151.84K
Feb 21, 2025	4.06	4.08	3.92	3.94	164.5K
Feb 20, 2025	3.98	4.09	3.95	3.98	99.9K
Feb 19, 2025	4.18	4.20	3.97	4.00	150.23K
Feb 18, 2025	4.46	4.63	4.11	4.13	149.08K
Feb 14, 2025	4.31	4.48	4.23	4.46	82.51K
Feb 13, 2025	4.12	4.33	4.04	4.29	133.57K
Feb 12, 2025	4.01	4.13	3.85	4.09	129.95K
Feb 11, 2025	4.33	4.34	4.00	4.03	401.2K
Feb 10, 2025	4.34	4.93	4.32	4.44	244.19K
Feb 07, 2025	4.37	4.54	4.28	4.30	130K

Contact Details

Redwood City, CA 94063

United States

Website: https://www.adverum.comContact: 650 656 9323

About Company

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

Frequently Asked Questions

What is the current Adverum Biotechnologies, Inc. (ADVM) stock price?

Adverum Biotechnologies, Inc. (NASDAQ: ADVM) stock price is $4.58 in the last trading session. During the trading session, ADVM stock reached the peak price of $4.70 while $4.52 was the lowest point it dropped to. The percentage change in ADVM stock occurred in the recent session was -0.87% while the dollar amount for the price change in ADVM stock was -$0.04.

ADVM's industry and sector of operation?

The NASDAQ listed ADVM is part of Biotechnology industry that operates in the broader Healthcare sector. Adverum Biotechnologies, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ADVM?

Ms. Nancy E. Pecota
Principal Accounting Officer
Mr. Michael Steel
Senior Vice President of Quality
Dr. Brigit Riley Ph.D.
Chief Scientific Officer
Mr. John W. Rakow J.D.
Senior Vice President & Gen. Counsel
Dr. Laurent Fischer
Pres, Chief Executive Officer & Director
Dr. Jim Wang Ph.D.
Chief Regulatory Officer
Mr. Heikki Jouttijarvi
Senior Vice President & Head of Technical Operations
Ms. Carla Fiankan
Senior Vice President of Regulatory Affairs
Mr. Kishor Peter Soparkar J.D.
Chief Operating Officer
Ms. Dena House
Senior Vice President of HR, Organizational Devel. & Learning
Dr. Setareh Seyedkazemi Pharm.D.
Chief Devel. Officer
Dr. Richard L. Beckman M.D.
Chief Medical Officer
Ms. Linda M. Rubinstein M.A.
Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer

How ADVM did perform over past 52-week?

ADVM's closing price is 30.11% higher than its 52-week low of $3.52 where as its distance from 52-week high of $19.10 is -78.09%.

How many employees does ADVM have?

Number of ADVM employees currently stands at 121.

Link for ADVM official website?

Official Website of ADVM is: https://www.adverum.com

How do I contact ADVM?

ADVM could be contacted at phone 650 656 9323 and can also be accessed through its website. ADVM operates from 800 Saginaw Drive, Redwood City, CA 94063, United States.

How many shares of ADVM are traded daily?

ADVM stock volume for the day was 77.24K shares. The average number of ADVM shares traded daily for last 3 months was 198.72K.

What is the market cap of ADVM currently?

The market value of ADVM currently stands at $95.28M with its latest stock price at $4.58 and 20.8M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	121
Beta	1.13
Sales or Revenue	$3.60M
5Y Sales Change%	12.595%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology